Lentiviral TetR Vector for Doxycycline-Regulated Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current inducible gene expression systems, such as the rtTA-based systems, suffer from toxicity issues and altered endogenous promoter expression patterns due to the requirement of a transactivator, leading to data misinterpretation and inefficiencies, particularly in the need for antibiotic selection and cloning for reproducibility.
Innovation Solution
A lentiviral vector system utilizing the TetR repressor, where the TetR repressor is expressed under the control of a constitutive promoter and binds to a TetO operator sequence, allowing for doxycycline-regulated gene expression without the need for antibiotic selection, using a single vector system that maintains endogenous promoter characteristics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If rtTA-based inducible gene expression systems are used, then gene expression can be regulated by tetracycline, but the transactivator causes toxicity and alters endogenous promoter expression patterns
Solution Approach 1:
The patent inverts the traditional rtTA approach by using a TetR repressor instead of a transactivator. The TetR repressor binds to TetO operator sequences to block promoter activity, and doxycycline binding releases this repression. This inversion eliminates the need for transactivators and their associated toxicity while maintaining inducible gene expression regulation capability.
Solution Approach 2:
The patent extracts and removes the transactivator component from the system, retaining only the essential regulatory elements (TetR repressor, TetO operator, and promoter). By eliminating the transactivator domain, the system achieves gene expression regulation without the harmful toxic effects and unwanted activation of endogenous promoters.
2Reliability
If TetR-based systems are used to block promoter activity, then endogenous promoter characteristics are maintained, but high concentrations of TetR are required which necessitate antibiotic selection and cloning
Solution Approach 1:
The patent merges the TetR repressor expression cassette and the regulated gene expression cassette into a single lentiviral vector. This all-in-one design eliminates the need for separate vector systems, antibiotic selection markers, and cloning steps required by previous TetR-based systems, while maintaining the ability to block promoter activity and preserve endogenous promoter characteristics.
Solution Approach 2:
The lentiviral vector is designed to perform multiple functions simultaneously: it delivers the TetR repressor, provides the regulatory elements for doxycycline-induced gene expression, and enables stable integration into the host genome without requiring antibiotic selection. This multi-functional design simplifies the overall system while maintaining reliability.
3Productivity
If high concentrations of TetR are used to block promoter activity, then gene expression is effectively repressed, but the system requires antibiotic selection and cloning for reproducibility
Solution Approach 1:
The patent combines the TetR expression and gene regulation elements into a single lentiviral vector, eliminating the need for separate antibiotic selection steps and cloning procedures. The vector achieves effective gene repression at high TetR concentrations while maintaining ease of manufacture through its integrated design.
4Adaptability or versatility
If transactivators are used for transcriptional activity, then gene expression can be induced, but the transactivator may activate cellular genes and cause data misinterpretation
Solution Approach 1:
The patent inverts the transcriptional activation approach by using repression instead. The TetR repressor blocks transcription by binding to TetO operator sequences, and doxycycline binding releases this repression to allow transcription. This inversion eliminates the risk of transactivators incorrectly activating cellular genes, thereby preserving data accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient, stable, and reproducible doxycycline-responsive cell line generation with minimal leakiness and high inducibility, overcoming toxicity and selection challenges of existing systems.
Implementation Method 1
the binding of the transcriptional repressor to said binding site inhibits the transcriptional activity of the promoter
Implementation Method 2
the regulatable transcriptional repressor is capable of specifically binding to the binding site in the transcriptional regulatory sequence in the absence but not in the presence of a ligand thereof
Data Source
Figure 1A~1B
Figure 2A
Figure 2B
AI summary
The invention relates to expression systems useful for regulated expression of a gene of interest based on the constitutive expression of the original TetR repressor and the expression of the polynucleotide driven by a constitutive promoter operably linked to an operator sequence for a tetracycline operator sequence. The system can be provided as two different polynucleotides or as an all-in-one vector. The invention also relates to vectors, host cells and viral particles according to the invention as well as to the uses thereof for in vitro and in vivo production of products of interest or for therapy.